The functional loss of PTEN is associated with advanced cancer progression, high Gleason grade, and overall poor prognosis, underlining the need for chemotherapeutic options for tumors with active PI3K/Akt signaling [39]–[41]. This evidence concerns the gene PTEN and cancer.